Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg.

Pedro-Antonio RegidorSantiago PalaciosEnrico Colli

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2022)

, and smokers using the DRSP only oral contraceptive product is described.Herby a higher contraceptive efficacy in these patients that additionally benefit from estrogen-free contraceptive methods is expected.

Keyphrases

cardiovascular risk factors
end stage renal disease
newly diagnosed
chronic kidney disease
cardiovascular disease
metabolic syndrome
prognostic factors
atrial fibrillation
smoking cessation
type diabetes